+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Companion Diagnostics"

Breast Cancer Diagnostic and Drug Technologies: Global Markets - Product Thumbnail Image

Breast Cancer Diagnostic and Drug Technologies: Global Markets

  • Report
  • November 2019
  • 150 Pages
  • Global
From
From
From
From
United States Liquid Biopsy Growth Opportunities - Product Thumbnail Image

United States Liquid Biopsy Growth Opportunities

  • Report
  • February 2022
  • 73 Pages
  • United States
From
From
Oncology Diagnostics in IVD Growth Opportunities - Product Thumbnail Image

Oncology Diagnostics in IVD Growth Opportunities

  • Report
  • July 2023
  • 145 Pages
  • Global
From
From
Loading Indicator

The Companion Diagnostics market is a subset of the biotechnology industry that focuses on the development and commercialization of diagnostic tests that are used to identify patients who are likely to benefit from a particular therapeutic. These tests are used to identify the presence of a specific biomarker or genetic mutation that is associated with a particular therapeutic. The Companion Diagnostics market is driven by the increasing demand for personalized medicine, which is tailored to the individual patient's genetic makeup. This has led to the development of more sophisticated tests that can detect a wider range of biomarkers and mutations. The Companion Diagnostics market is highly competitive, with a number of companies offering a range of tests. Examples of companies in the market include Roche Diagnostics, Abbott Laboratories, Qiagen, Illumina, and Thermo Fisher Scientific. Show Less Read more